BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 11775491)

  • 1. Genetic aspects of chronic pancreatitis: insights into aetiopathogenesis and clinical implications.
    Truninger K; Ammann RW; Blum HE; Witt H
    Swiss Med Wkly; 2001 Oct; 131(39-40):565-74. PubMed ID: 11775491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CFTR, PRSS1 and SPINK1 mutations in the development of pancreatitis in Brazilian patients.
    Bernardino AL; Guarita DR; Mott CB; Pedroso MR; Machado MC; Laudanna AA; Tani CM; Almeida FL; Zatz M
    JOP; 2003 Sep; 4(5):169-77. PubMed ID: 14526128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The course of genetically determined chronic pancreatitis.
    Keim V; Witt H; Bauer N; Bodeker H; Rosendahl J; Teich N; Mossner J
    JOP; 2003 Jul; 4(4):146-54. PubMed ID: 12853682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants.
    Teich N; Bauer N; Mössner J; Keim V
    Am J Gastroenterol; 2002 Feb; 97(2):341-6. PubMed ID: 11866271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene mutations in children with chronic pancreatitis.
    Witt H
    Pancreatology; 2001; 1(5):432-8. PubMed ID: 12120220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the relative contribution of three genes-the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis.
    Audrézet MP; Chen JM; Le Maréchal C; Ruszniewski P; Robaszkiewicz M; Raguénès O; Quéré I; Scotet V; Férec C
    Eur J Hum Genet; 2002 Feb; 10(2):100-6. PubMed ID: 11938439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serine protease inhibitor Kazal type 1 mutations and pancreatitis.
    Schneider A
    Gastroenterol Clin North Am; 2004 Dec; 33(4):789-806. PubMed ID: 15528018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for human cationic trypsinogen (PRSS1) and trypsinogen inhibitor gene (SPINK1) mutations in a Finnish family with hereditary pancreatitis.
    Räty S; Piironen A; Babu M; Pelli H; Sand J; Uotila S; Nordback I; Herzig KH
    Scand J Gastroenterol; 2007 Aug; 42(8):1000-5. PubMed ID: 17613931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of CFTR, SPINK1, PRSS1 and AAT mutations in children with acute or chronic pancreatitis.
    Sobczyńska-Tomaszewska A; Bak D; Oralewska B; Oracz G; Norek A; Czerska K; Mazurczak T; Teisseyre M; Socha J; Zagulski M; Bal J
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):299-306. PubMed ID: 16954950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis.
    Witt H; Luck W; Hennies HC; Classen M; Kage A; Lass U; Landt O; Becker M
    Nat Genet; 2000 Jun; 25(2):213-6. PubMed ID: 10835640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1 mutations.
    Felderbauer P; Hoffmann P; Einwächter H; Bulut K; Ansorge N; Schmitz F; Schmidt WE
    BMC Gastroenterol; 2003 Nov; 3():34. PubMed ID: 14641934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic counseling for hereditary pancreatitis--the role of molecular genetics testing for the cationic trypsinogen gene, cystic fibrosis and serine protease inhibitor Kazal type 1.
    Ellis I
    Gastroenterol Clin North Am; 2004 Dec; 33(4):839-54. PubMed ID: 15528021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cationic trypsinogen mutations and pancreatitis.
    Howes N; Greenhalf W; Stocken DD; Neoptolemos JP
    Gastroenterol Clin North Am; 2004 Dec; 33(4):767-87. PubMed ID: 15528017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene.
    Felderbauer P; Karakas E; Fendrich V; Bulut K; Horn T; Lebert R; Holland-Letz T; Schmitz F; Bartsch D; Schmidt WE
    Am J Gastroenterol; 2008 Feb; 103(2):368-74. PubMed ID: 18076731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of PRSS1 mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis.
    Chandak GR; Idris MM; Reddy DN; Mani KR; Bhaskar S; Rao GV; Singh L
    Gut; 2004 May; 53(5):723-8. PubMed ID: 15082592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic aspects of chronic pancreatitis.
    Teich N; Mössner J
    Med Sci Monit; 2004 Dec; 10(12):RA325-8. PubMed ID: 15567996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic prevalence and characteristics in children with recurrent pancreatitis.
    Sultan M; Werlin S; Venkatasubramani N
    J Pediatr Gastroenterol Nutr; 2012 May; 54(5):645-50. PubMed ID: 22094894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis.
    Drenth JP; te Morsche R; Jansen JB
    Gut; 2002 May; 50(5):687-92. PubMed ID: 11950817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the serine protease inhibitor, Kazal type 1 gene, in patients with idiopathic chronic pancreatitis.
    Truninger K; Witt H; Köck J; Kage A; Seifert B; Ammann RW; Blum HE; Becker M
    Am J Gastroenterol; 2002 May; 97(5):1133-7. PubMed ID: 12014716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of CFTR, PRSS1, and SPINK1 mutations in 381 patients with pancreatitis.
    Keiles S; Kammesheidt A
    Pancreas; 2006 Oct; 33(3):221-7. PubMed ID: 17003641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.